tiprankstipranks
QuantRx Biomedical Corporation (QTXB)
OTHER OTC:QTXB
US Market
Holding QTXB?
Track your performance easily

QuantRx Biomedical (QTXB) Income Statement

3 Followers

QuantRx Biomedical Income Statement

Last quarter (Q ), QuantRx Biomedical's total revenue was $―, a decrease of ― from the same quarter last year. In Q, QuantRx Biomedical's net income was $-61.17K. See QuantRx Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
------
Cost of Revenue
--$ 10.50K$ 84.00K$ 54.00K-
Gross Profit
--$ -10.50K$ -84.00K$ -54.00K-
Operating Expense
$ 44.32K$ 43.38K$ 50.12K$ 117.74K$ 181.88K$ 172.99K
Operating Income
$ -44.32K$ -43.38K$ -60.62K$ -201.74K$ -235.88K$ -172.99K
Net Non Operating Interest Income Expense
$ -216.19K$ -216.66K$ -216.72K$ -198.18K$ -232.17K$ -245.41K
Other Income Expense
$ -500.00K$ -500.00K$ -24.61K$ -500.00K$ -8.06K$ -1.46M
Pretax Income
$ -260.51K$ -260.04K$ -252.73K$ -621.92K$ -736.85K$ 869.14K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -260.51K$ -260.04K$ -252.73K$ -621.92K$ -736.85K$ 869.14K
Basic EPS
--$ -0.01---
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.01$ -0.01$ 0.01
Basic Average Shares
$ 314.79M$ 78.70M$ 78.70M$ 78.70M$ 78.70M$ 78.70M
Diluted Average Shares
$ 314.79M$ 78.70M$ 78.70M$ 62.19M$ 78.70M$ 130.44M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 44.32K$ 43.38K$ 60.62K$ 201.74K$ 235.88K$ 172.99K
Net Income From Continuing And Discontinued Operation
$ -323.52K$ -260.04K$ -252.73K$ -621.92K$ -736.85K$ 869.14K
Normalized Income
------
Interest Expense
------
EBIT
$ -44.32K$ -43.38K$ -36.01K$ -423.74K$ -504.68K$ 1.11M
EBITDA
$ -44.32K$ -43.38K$ -36.01K$ -423.74K$ -504.68K$ 1.13M
Currency in USD

QuantRx Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis